Opaleye Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,525
| Closed | -$1.05M | – | 51 |
|
|
2021
Q1 | $1.05M | Buy |
5,525
+2,537
| +85% | +$481K | 0.15% | 55 |
|
|
2020
Q4 | $375K | Buy |
+2,988
| New | +$375K | 0.05% | 57 |
|
|
2020
Q3 | – | Sell |
-3,202
| Closed | -$385K | – | 61 |
|
|
2020
Q2 | $385K | Sell |
3,202
-23,968
| -88% | -$2.88M | 0.08% | 47 |
|
|
2020
Q1 | $2.73M | Sell |
27,170
-952
| -3% | -$95.7K | 0.72% | 31 |
|
|
2019
Q4 | $6.73M | Buy |
28,122
+4,059
| +17% | +$971K | 1.32% | 32 |
|
|
2019
Q3 | $3.95M | Sell |
24,063
-9,375
| -28% | -$1.54M | 1.43% | 29 |
|
|
2019
Q2 | $7.89M | Buy |
33,438
+1,563
| +5% | +$369K | 2.41% | 18 |
|
|
2019
Q1 | $8.4M | Buy |
31,875
+312
| +1% | +$82.2K | 2.33% | 16 |
|
|
2018
Q4 | $2.88M | Sell |
31,563
-13,750
| -30% | -$1.25M | 1.07% | 29 |
|
|
2018
Q3 | $8.71M | Buy |
45,313
+10,938
| +32% | +$2.1M | 2.22% | 12 |
|
|
2018
Q2 | $7.43M | Buy |
+34,375
| New | +$7.43M | 1.92% | 17 |
|